Published in Circulation on December 26, 2006
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol (2011) 2.25
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22
Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C. Am J Nephrol (2009) 2.10
Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int (2012) 1.93
Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study. Am J Kidney Dis (2011) 1.83
Overlap between common genetic polymorphisms underpinning kidney traits and cardiovascular disease phenotypes: the CKDGen consortium. Am J Kidney Dis (2013) 1.52
Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study. Nephrol Dial Transplant (2009) 1.51
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med (2008) 1.45
Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Adv Chronic Kidney Dis (2010) 1.44
Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (2008) 1.34
Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol (2008) 1.31
Cystatin C--a paradigm of evidence based laboratory medicine. Clin Biochem Rev (2008) 1.17
Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study. Am J Kidney Dis (2012) 1.09
Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol (2010) 1.07
Cystatin C: a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev (2012) 1.06
Novel biomarkers in chronic heart failure. Nat Rev Cardiol (2012) 1.06
Association of cystatin C with poor exercise capacity and heart rate recovery: data from the heart and soul study. Am J Kidney Dis (2007) 1.05
Cystatin C and risk of heart failure in the Physicians' Health Study (PHS). Am Heart J (2007) 1.04
The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis. Am J Epidemiol (2011) 1.02
A biomarker panel for peripheral arterial disease. Vasc Med (2008) 1.01
Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology (2008) 0.99
Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events. Circ Heart Fail (2012) 0.97
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study. Am Heart J (2012) 0.97
Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study. Arterioscler Thromb Vasc Biol (2011) 0.97
Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev (2012) 0.96
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol (2013) 0.94
Lack of Association between Serum Cystatin C Levels and Coronary Artery Disease in Diabetic Patients. Korean Diabetes J (2010) 0.94
Cystatin C is associated with cardiovascular risk factors and metabolic syndrome in Aboriginal youth. Pediatr Nephrol (2007) 0.93
Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis. Nephrol Dial Transplant (2010) 0.92
Kidney function and mortality in octogenarians: Cardiovascular Health Study All Stars. J Am Geriatr Soc (2012) 0.91
Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals. HIV Med (2013) 0.90
Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. Atherosclerosis (2011) 0.88
Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study. Am J Kidney Dis (2010) 0.87
Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? PLoS One (2013) 0.86
Cystatin C reduction ratio depends on normalized blood liters processed and fluid removal during hemodialysis. Clin J Am Soc Nephrol (2010) 0.85
Cardiorenal syndrome type 4: a review. Cardiorenal Med (2013) 0.85
Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis. J Rheumatol (2011) 0.84
The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: multiethnic study of atherosclerosis. Cardiol Res Pract (2011) 0.84
Biomarkers of atherosclerosis: clinical applications. Curr Cardiol Rep (2008) 0.83
Association between kidney function and telomere length: the heart and soul study. Am J Nephrol (2012) 0.83
Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol (2010) 0.82
Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents. Heart Vessels (2015) 0.82
Association between Cystatin C and MRI Measures of Left Ventricular Structure and Function: Multi-Ethnic Study of Atherosclerosis. Int J Nephrol (2011) 0.81
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
Serum cystatin C concentration as an independent marker for hypertensive left ventricular hypertrophy. J Geriatr Cardiol (2013) 0.81
Evaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistances. World J Clin Cases (2015) 0.80
Application of cystatin C reduction ratio to high-flux hemodialysis as an alternative indicator of the clearance of middle molecules. Korean J Intern Med (2010) 0.80
Limited value of cystatin-C over estimated glomerular filtration rate for heart failure risk stratification. PLoS One (2012) 0.79
Relationship between serum cystatin C and serum adiponectin level in type 2 diabetic patients. Clin Exp Nephrol (2011) 0.79
Cystatin C Is Not Causally Related to Coronary Artery Disease. PLoS One (2015) 0.79
Kidney function and estimated vascular risk in patients with primary dyslipidemia. Open Cardiovasc Med J (2009) 0.79
Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers. Paediatr Drugs (2014) 0.78
Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol (2011) 0.78
Dietary protein intake and change in estimated GFR in the Cardiovascular Health Study. Nutrition (2013) 0.78
Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation (2015) 0.77
Diminished renal function and the incidence of heart failure. Curr Cardiol Rev (2009) 0.77
Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94). Nephrol Dial Transplant (2010) 0.76
Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol (2014) 0.76
Is cystatin C an important prognostic marker independent of renal function? J Am Coll Cardiol (2010) 0.76
Relationship of urine dopamine with phosphorus homeostasis in humans: the heart and soul study. Am J Nephrol (2012) 0.76
Cystatin C in children on chronic hemodialysis. Pediatr Nephrol (2012) 0.76
Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study. BMJ Open (2012) 0.75
Associations of Conventional Echocardiographic Measures with Incident Heart Failure and Mortality: The Chronic Renal Insufficiency Cohort. Clin J Am Soc Nephrol (2016) 0.75
Plasma Levels of Middle Molecules to Estimate Residual Kidney Function in Haemodialysis without Urine Collection. PLoS One (2015) 0.75
Cystatin C in Acute Coronary Syndrome. EJIFCC (2013) 0.75
Soluble endothelial cell selective adhesion molecule and cardiovascular outcomes in patients with stable coronary disease: A report from the Heart and Soul Study. Atherosclerosis (2015) 0.75
Cystatin C, creatinine, and albuminuria: bringing risk into 3 dimensions. Am J Kidney Dis (2012) 0.75
Relationship between serum cystatin C and polycystic ovary syndrome. Iran J Reprod Med (2013) 0.75
Higher Levels of Cystatin C Are Associated with Extracranial Carotid Artery Steno-Occlusive Disease in Patients with Noncardioembolic Ischemic Stroke. Cerebrovasc Dis Extra (2016) 0.75
Cystatin C and Risk of Diabetes and the Metabolic Syndrome - Biomarker and Genotype Association Analyses. PLoS One (2016) 0.75
Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome. BMC Cardiovasc Disord (2017) 0.75
Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study. Haematologica (2012) 0.75
Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus. Vasc Health Risk Manag (2011) 0.75
Cystatin C, other markers of kidney disease, and incidence of age-related cataract. Arch Ophthalmol (2008) 0.75
Biomarkers in heart failure: a clinical review. Heart Fail Rev (2008) 0.75
Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study. J Am Coll Cardiol (2016) 0.75
Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus. Clin Rheumatol (2017) 0.75
[Biomarkers in cardiology--state of the art 2007]. Wien Med Wochenschr (2007) 0.75
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med (2005) 15.30
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med (2004) 11.52
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int (2004) 6.32
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2002) 4.52
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis (2000) 4.44
Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest (1999) 4.23
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med (2002) 3.92
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol (2005) 3.48
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int (1995) 2.97
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95
Measurement of renal function in chronic renal disease. Kidney Int (1990) 2.72
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55
Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. Pediatrics (1998) 2.50
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med (1999) 2.05
Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study. J Am Soc Nephrol (2003) 1.72
Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation (2004) 1.67
Clinical evaluation of kidney function--glomerular function. N Engl J Med (1971) 1.63
Microalbuminuria: definition, detection, and clinical significance. J Clin Hypertens (Greenwich) (2004) 1.59
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation (2003) 1.40
Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem (1998) 1.39
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J (2005) 1.39
Gender and the progression of renal disease. Curr Opin Nephrol Hypertens (2001) 1.33
Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. J Am Coll Cardiol (2001) 0.92
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40
Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med (2010) 12.04
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol (2004) 11.23
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N Engl J Med (2013) 7.54
Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA (2002) 7.20
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol (2006) 6.66
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
Functional status of elderly adults before and after initiation of dialysis. N Engl J Med (2009) 6.45
Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int (2004) 6.04
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Predialysis nephrology care of older patients approaching end-stage renal disease. Arch Intern Med (2011) 5.11
Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol (2006) 4.95
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int (2009) 4.72
The relative safety of ephedra compared with other herbal products. Ann Intern Med (2003) 4.65
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol (2005) 3.96
Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol (2008) 3.93
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med (2002) 3.92
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol (2002) 3.83
Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease. Ann Intern Med (2013) 3.83
Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med (2007) 3.80
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol (2009) 3.28
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 3.14
A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12
The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant (2010) 3.10
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Nephrology consultation in acute renal failure: does timing matter? Am J Med (2002) 2.95
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation (2003) 2.82
Acute renal failure definitions and classification: time for change? J Am Soc Nephrol (2003) 2.81
Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol (2002) 2.74
Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation (2010) 2.71
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65
Significance of frailty among dialysis patients. J Am Soc Nephrol (2007) 2.62
An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. Value Health (2009) 2.60
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol (2006) 2.56
Cystatin C and mortality risk in the elderly: the health, aging, and body composition study. J Am Soc Nephrol (2005) 2.55
Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int (2005) 2.54
Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int (2004) 2.52
Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care (2010) 2.51
Cognitive impairment in chronic kidney disease. J Am Geriatr Soc (2004) 2.50
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med (2009) 2.39
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39
The case against calcium-based phosphate binders. Clin J Am Soc Nephrol (2006) 2.38
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr (2004) 2.37
Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry (2007) 2.37
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32
Weekend hospital admission, acute kidney injury, and mortality. J Am Soc Nephrol (2010) 2.30
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23